Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1461531

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1461531

Global Nerve Repair and Regeneration Market Size, Share, Growth Analysis, By Type(Neurostimulation and Neuromodulation Devices, and Biomaterials), By Application(Peripheral Nerve Injury, Epilepsy) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Nerve Repair And Regeneration Market size was valued at USD 8.2 Billion in 2022 and is poised to grow from USD 9.2 Billion in 2023 to USD 23.05 Billion by 2031, at a CAGR of 12.17% during the forecast period (2024-2031).

The upward trajectory of the global market is fueled by the escalating prevalence of neurological disorders worldwide, including Parkinson's disease, Alzheimer's, and various Central Nervous System (CNS) disorders. This surge in afflicted individuals has spurred a heightened demand for effective treatment options. Major players in the medical sector are actively involved in bolstering their product pipelines to meet this escalating demand, channeling significant efforts into research and development endeavors to drive technological advancements aimed at enhancing the efficacy of neurological disorder treatments. These strides are poised to substantially fuel market expansion. Furthermore, the proliferation of therapeutic options for diverse CNS disorders amplifies market prospects. Notably, therapies utilizing processed nerve allografts have exhibited promising outcomes in reinstating motor and sensory nerve functions among patients grappling with upper extremity nerve impairments. A study presented at the annual meeting of the American Society for Surgery of the Hand revealed that 75% of patients treated with a specific nerve allograft witnessed motor function recovery, with 85% experiencing restored sensory nerve function. Additionally, heightened public awareness regarding neurological disorders, coupled with factors encompassing environmental influences, lifestyle choices, genetics, nutrition, and physical injuries, has cultivated a deeper understanding of these conditions. This augmented awareness has notably contributed to the escalating demand for nerve repair and regeneration solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair And Regeneration Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair And Regeneration Market Segmental Analysis

Global Nerve Repair and Regeneration Market is segmented by Type, application, and region. Based on Type, the market can be segmented into neurostimulation and neuromodulation devices, and biomaterials. Based on application, the market is segmented into peripheral nerve injury, epilepsy, Parkinson's disease, and Alzheimer's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Nerve Repair And Regeneration Market

A major catalyst propelling the nerve repair and regeneration market forward is the escalating prevalence of neurological disorders worldwide, encompassing ailments like Alzheimer's disease, Parkinson's disease, and spinal cord injuries. As the frequency of these conditions rises, there's a pressing requirement for efficient treatment avenues, thus spurring an upsurge in the demand for nerve repair and regeneration therapies. This momentum is fueled by various factors including aging demographics, shifts in lifestyles, environmental impacts, and genetic susceptibilities, all underscoring the imperative for inventive solutions within the market.

Restraints in the Global Nerve Repair And Regeneration Market

A key challenge within the nerve repair and regeneration sector is the substantial expense linked to cutting-edge treatments and therapies. The advancement and adoption of innovative technologies and regenerative approaches necessitate significant investments in research, development, and production. These expenses can create significant hurdles for patients seeking access, particularly in areas with constrained healthcare resources or insufficient insurance coverage. Moreover, the reimbursement environment for nerve repair and regeneration procedures may not consistently favor affordability and accessibility for patients.

Market Trends of the Global Nerve Repair And Regeneration Market

A notable trend in the nerve repair and regeneration sector involves a heightened emphasis on regenerative medicine and stem cell therapies. Both researchers and companies are delving into the capabilities of stem cells to stimulate nerve regrowth and revive neurological functions, presenting a promising avenue for patients grappling with nerve injuries or degenerative conditions. Stem cell-based methods present the opportunity to replenish damaged or lost cells, offering hopeful prospects for innovative treatments tailored to individual needs, thereby indicating the industry's movement towards regenerative and personalized therapeutic approaches.

Product Code: SQMIG35I2162

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Nerve Repair and Regeneration Market by Type

  • Market Overview
  • Neurostimulation and Neuromodulation Devices
  • and Biomaterials

Global Nerve Repair and Regeneration Market by Application

  • Market Overview
  • Peripheral Nerve Injury
  • Epilepsy
  • Parkinson's Disease
  • and Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AxoGen, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nevro Corp (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cyberonics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Orthofix Medical Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polyganics (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nuvectra Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polyganics BV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTime Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Collagen Matrix, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Synovis Micro Companies Alliance, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • StimGuard LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nexeon MedSystems Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Checkpoint Surgical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!